| 000 | 01569 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518002756.0 | ||
| 264 | 0 | _c20190417 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a2211-0356 | ||
| 024 | 7 |
_a10.1016/j.msard.2018.09.035 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSevera, Martina | |
| 245 | 0 | 0 |
_aThymosins in multiple sclerosis and its experimental models: moving from basic to clinical application. _h[electronic resource] |
| 260 |
_bMultiple sclerosis and related disorders _cJan 2019 |
||
| 300 |
_a52-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEncephalomyelitis, Autoimmune, Experimental _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aOligodendrocyte Precursor Cells _xdrug effects |
| 650 | 0 | 4 |
_aThymosin _xtherapeutic use |
| 650 | 0 | 4 | _aTranslational Research, Biomedical |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aZhang, Jing | |
| 700 | 1 | _aGiacomini, Elena | |
| 700 | 1 | _aRizzo, Fabiana | |
| 700 | 1 | _aEtna, Marilena Paola | |
| 700 | 1 | _aCruciani, Melania | |
| 700 | 1 | _aGaraci, Enrico | |
| 700 | 1 | _aChopp, Michael | |
| 700 | 1 | _aCoccia, Eliana Marina | |
| 773 | 0 |
_tMultiple sclerosis and related disorders _gvol. 27 _gp. 52-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.msard.2018.09.035 _zAvailable from publisher's website |
| 999 |
_c28935084 _d28935084 |
||